Becton Dickinson's fiscal fourth-quarter earnings rose sharply as the acquisition of Edward Lifesciences' critical-care supply unit bolstered revenue growth.
For the quarter ended Sept. 30, the medical-device maker posted net income of $421 million, or $1.45 a share, up from $108 million, or 37 cents a share, a year earlier.
Adjusted earnings, which strip out certain one-time items to $3.81 a share, topping the $3.77 a share forecast by analysts polled by FactSet.
The Franklin Lakes, N.J., company's fourth-quarter revenue rose 6.9% to $5.44 billion, topping the average Wall Street target of $5.38 billion.
Sales in the U.S. rose 8.2% to $3.12 billion. International revenue rose 5.1% to $2.32 billion.
For fiscal year 2025, Becton forecast adjusted earnings of $14.25-to-$14.60 a share on revenue of $21.9 billion to $22.1 billion, representing sales growth of 8.9%-to-9.4% from fiscal 2024.
Becton recently acquired Edward Lifesciences' critical-care unit, which makes heart monitors and other equipment, for $4.2 billion in cash.
The company also boosted its quarterly dividend by 9.5% to $1.04 a share, payable Dec. 31 to holders of record as of Dec. 9.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.